Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

D Armenia; D Di Carlo; Andrea CALCAGNO; GIULIA VENDEMIATI; F Forbici; A Bertoli; G Berno; S Carta; F Continenza; V Fedele; R Bellagamba; S Cicalini; A Ammassari; R Libertone; M Zaccarelli; V Ghisetti; M Andreoni; F Ceccherini Silberstein; Stefano BONORA; Giovanni DI PERRI; A Antinori; C. F Perno; M. M. Santoro

doi:10.1093/jac/dkw512

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

D Armenia
, D Di Carlo
, Andrea CALCAGNO
, GIULIA VENDEMIATI
, F Forbici
, A Bertoli
, G Berno
, S Carta
, F Continenza
, V Fedele
, R Bellagamba
, S Cicalini
, A Ammassari
, R Libertone
, M Zaccarelli
, V Ghisetti
, M Andreoni
, F Ceccherini Silberstein
, Stefano BONORA
, Giovanni DI PERRI

A Antinori, C. F Perno, M. M. Santoro

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).

Original language	English
Pages (from-to)	1-11
Number of pages	11
Journal	Journal of Antimicrobial Chemotherapy
DOIs	https://doi.org/10.1093/jac/dkw512
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/jac/dkw512

https://hdl.handle.net/11579/216822

Cite this

Armenia, D., Di Carlo, D., CALCAGNO, A., VENDEMIATI, GIULIA., Forbici, F., Bertoli, A., Berno, G., Carta, S., Continenza, F., Fedele, V., Bellagamba, R., Cicalini, S., Ammassari, A., Libertone, R., Zaccarelli, M., Ghisetti, V., Andreoni, M., Ceccherini Silberstein, F., BONORA, S., ... Santoro, M. M. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. Journal of Antimicrobial Chemotherapy, 1-11. https://doi.org/10.1093/jac/dkw512

@article{cce6f046ed2245ffb32ff40106fc42bc,

title = "Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen",

abstract = "To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).",

author = "D Armenia and \{Di Carlo\}, D and Andrea CALCAGNO and GIULIA VENDEMIATI and F Forbici and A Bertoli and G Berno and S Carta and F Continenza and V Fedele and R Bellagamba and S Cicalini and A Ammassari and R Libertone and M Zaccarelli and V Ghisetti and M Andreoni and \{Ceccherini Silberstein\}, F and Stefano BONORA and \{DI PERRI\}, Giovanni and A Antinori and Perno, \{C. F\} and Santoro, \{M. M.\}",

year = "2016",

doi = "10.1093/jac/dkw512",

language = "English",

pages = "1--11",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

}

Armenia, D, Di Carlo, D, CALCAGNO, A, VENDEMIATI, GIULIA, Forbici, F, Bertoli, A, Berno, G, Carta, S, Continenza, F, Fedele, V, Bellagamba, R, Cicalini, S, Ammassari, A, Libertone, R, Zaccarelli, M, Ghisetti, V, Andreoni, M, Ceccherini Silberstein, F, BONORA, S, DI PERRI, G, Antinori, A, Perno, CF & Santoro, MM 2016, 'Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen', Journal of Antimicrobial Chemotherapy, pp. 1-11. https://doi.org/10.1093/jac/dkw512

TY - JOUR

T1 - Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

AU - Armenia, D

AU - Di Carlo, D

AU - CALCAGNO, Andrea

AU - VENDEMIATI, GIULIA

AU - Forbici, F

AU - Bertoli, A

AU - Berno, G

AU - Carta, S

AU - Continenza, F

AU - Fedele, V

AU - Bellagamba, R

AU - Cicalini, S

AU - Ammassari, A

AU - Libertone, R

AU - Zaccarelli, M

AU - Ghisetti, V

AU - Andreoni, M

AU - Ceccherini Silberstein, F

AU - BONORA, Stefano

AU - DI PERRI, Giovanni

AU - Antinori, A

AU - Perno, C. F

AU - Santoro, M. M.

PY - 2016

Y1 - 2016

N2 - To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).

AB - To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).

UR - https://iris.uniupo.it/handle/11579/216822

U2 - 10.1093/jac/dkw512

DO - 10.1093/jac/dkw512

M3 - Article

SN - 0305-7453

SP - 1

EP - 11

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this